Nanoparticles, Genome Therapy & Antibodies - The Zhou Research Lab at Yale School of Medicine
00:02:36
Nanoparticles, Genome Therapy & Antibodies - The Zhou Research Lab at Yale School of Medicine
The Zhou Laboratory develops and translates next-generation therapeutics by integrating chemistry, materials science, and bioengineering with disease-focused biology. Our research centers on two interconnected areas:
Delivery technologies for genetic medicines and targeted therapeutics: We develop nonviral delivery platforms for genetic medicines, with particular emphasis on genome and epigenome editing, as well as targeted delivery of therapeutic agents to challenging tissues, including the central nervous system (CNS). Our core technology platforms include polymeric and lipid nanoparticles for nonviral gene delivery and CNS-targeted drug delivery; STEP engineering strategies for cell- and tissue-selective delivery of genome- and epigenome-editing therapeutics; and cell-penetrating antibodies for cytosolic delivery of therapeutic payloads.
Pre-clinical evaluation in clinically relevant disease models: In close collaboration with colleagues across the campus and partner institutions, we evaluate these technology platforms in clinically relevant models of diverse genetic, neurologic, traumatic, and malignant diseases. Current areas of focus include, but are not limited to, neurofibromatosis, Alzheimer’s disease, Parkinson’s disease, Angelman syndrome, Prader–Willi syndrome, Rett syndrome, Spinal muscular atrophy, Amyotrophic lateral sclerosis, Smith–Magenis syndrome, Charcot–Marie–Tooth disease, neurotrauma, and cancer.
Our overarching goal is to translate innovative delivery technologies into clinically viable therapeutics. Several of these efforts are currently advancing toward clinical evaluation in the coming years.
Copy Link
We have many research opportunities for postdocs, grad students, and medical students interested in using both biology and chemistry to solve medical problems. We are particularly interested in recruiting talents postdoctoral candidates to join our lab at this moment. For more information, please check the postdoctoral opportunities page.
Copy Link
We thank the following for their current and past support of our research.
NIH/NINDS, NIH/NCI, NIH/NIBIB, NIH/NCATS, Connecticut Innovations, American Cancer Society, American Heart Association, Gilbert Family Foundation, American Brain Tumor Association, Patrys Limited, Matthew Larson Foundation, TheCureStartNow Foundation, Swebilius Foundation, VABC Foundation, and B*CURED foundation.
Copy Link